You are here: vision-research.eu » News

News

Johns Hopkins researchers develop new way to deliver sight-saving gene therapy to the retina

In experiments with rats, pigs and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the retina.

Third of children who need glasses aren't wearing them

It's a problem many teachers are familiar with, a student apparently struggling in class, but in fact just suffering from something that's easily fixed—vision problems—with an inexpensive pair of glasses.

New study on gene modulation may help prevent blindness

Genes borrowed from a spider turned Peter Parker into Spiderman. If scientists can use archaea--tiny organisms similar to bacteria--as a source of useful genes for humans, might it help prevent blindness one day?

Researchers find potential new treatment for diabetic retinopathy

About one in three diabetic patients develops diabetic retinopathy (DR), which can impair vision and lead to blindness.

Quantum gold rush: the private funding pouring into quantum start-ups

Robert Schoelkopf spent more than 15 years studying the building blocks of quantum computers until, in 2015, he decided it was time to start constructing one.

Two different treat-and-extend protocols with aflibercept in wet AMD suggest fewer injections

Researchers at the Helsinki Retina Research Group at the University of Helsinki, Finland report that while two treatment protocols – either moderate or rapid extensions – do not change the visual acuity or central subfield macular thickness (CSMT), the mean number of injections was lower and the treatment interval longer in the treat-and-extend group with rapid extensions.

New study suggests that the UK general public rank sight, hearing and balance as top three senses

Which of our senses is most important to us? We may intuitively understand that certain senses like sight or hearing are particularly valuable in our day-to-day lives.

First EJP RD General Assembly

The European Joint Program on Rare Diseases (EJP RD) held its first general assembly meeting on 17 – 19 September at the Medical University of Gdansk, Poland.

How older adults can make life easier and safer despite declining vision

The number of older Americans with low vision is expected to double in the coming years, as more people live longer. Low vision describes poor vision that can't be fixed or improved with glasses, contacts or surgery.

App can detect 'white eye' in children's photos to spot possible problems

A team of researchers from Baylor University, with assistance from staff at the Massachusetts Eye and Ear Infirmary, Harvard Medical School and the Dana-Farber Cancer Institute has developed and tested a smartphone app that is able to detect "white eye" in children by analyzing stored photographs.

Increased levels of RBP3 may protect and treat diabetic retinopathy

Research has shown that increased levels of retinol binding protein 3 (RBP3) may protect and treat diabetic retinopathy

VR game gives users 'eyes-on' experience with vision loss

In a virtual world, a knight in full armour sits in front of me, expectantly waiting for me to deal them some playing cards. As the game progresses, a large black spot grows in the middle of my vision.

China: How science made a superpower

The opening ceremony of the 2008 Olympic Games in Beijing featured ancient China’s four great inventions: the compass, printing press, paper and gunpowder. The lesson on display, as taught in classrooms across the country that today publishes the most research papers, is that Chinese innovation in science and technology changed the world.

Improving the quality of European Reference Networks for rare diseases

An article published in the Translational Science of Rare Diseases, intended to identify the most efficient strategies to improve the quality of European Reference Networks’ (ERNs).

An advance for drug-eluting contact lenses: Delivery to the back of the eye

Drug-eluting contact lenses, which gradually release drugs into the eye, offer a promising alternative to daily eye drops, which can be unpleasant and hard for patients to properly administer.